Where is the live CopyMark page for USPTO serial 79155398?

The live record is at https://getcopymark.com/trademark/79155398. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns DBV TECHNOLOGIES?

According to the public USPTO record for serial number 79155398, the listed owner(s) include: DBV TECHNOLOGIES, DBV TECHNOLOGIES (Société Anonyme), DBV TECHNOLOGIES (Société Anonyme), DBV TECHNOLOGIES (Société Anonyme).

What is USPTO serial number 79155398?

Serial number 79155398 is the USPTO application identifier for the mark DBV TECHNOLOGIES. It is used to track examination, publication, and registration of this trademark.

What is the current status of DBV TECHNOLOGIES?

DBV TECHNOLOGIES (79155398) currently shows USPTO status code 404 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Which trademark classes cover DBV TECHNOLOGIES?

The public record lists International Classes: 005, 010, 042, 044. Each class corresponds to categories of goods or services identified in the application or registration.

Trademark: DBV TECHNOLOGIES Serial# 79155398 | status 404; last event DETH | Trademark Info & Attorney Guidance

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with DBV TECHNOLOGIES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

James R. Menker

DREYFUS & ASSOCIÉS78 AVENUE RAYMOND POINCARÉF-75116 PARIS,FRANCE

Goods and services

Class	Description	Status	First use
005	Medicated adhesive devices in the nature of epicutaneous patches for enabling cutaneous or epicutaneous administration of medicated or pharmaceutical substances in powder form for humans and animals for the treatment of allergies, inflammatory and autoimmune diseases; epicutaneous patches featuring a preparation in powder form for medical purposes for the treatment of allergies, inflammatory and autoimmune diseases; medicated occlusion patches in the nature of epicutaneous patches for enabling the absorption of a medicated substance in powder form via the skin for the treatment of allergies, inflammatory and autoimmune diseases	SECTION 71 - CANCELLED	—
010	Medical apparatus, instruments and devices, namely, epicutaneous patches for the cutaneous or epicutaneous administration of substances of medicated or cosmetic substances in powder form for humans or animals sold without medication; occlusion patch dispensers for medical purposes; medical instruments using the electrostatic properties of a biocompatible support, namely, epicutaneous patches sold without medication	SECTION 71 - CANCELLED	—
042	Medical and scientific research in the field of immunotherapy, namely, designing scientific methods for epicutaneous immunotherapy without prior preparation of the skin other than simple and light cleaning in order to leave the cell structure of the skin intact; scientific research in the field of treating and caring for allergies; scientific research in the field of allergy treatment for a treatment to be applied repeatedly to the skin of the patient without prior preparation of the skin other than simple and light cleaning in order to leave the cell structure of the skin intact and thus avoiding the passage of the allergen into the blood; discovery and development of allergen drugs; medical and scientific research, namely, designing methods for treating allergies via the combination of allergens with immune cells in the skin; medical and scientific research, namely, designing methods for treating allergies via the application of a patch to the unbroken skin of the patient without prior preparation of the skin other than simple and light cleaning in order to leave the cell structure of the skin intact	SECTION 71 - CANCELLED	—
044	Medical services that use a desensitization method that uses immunotherapy; medical treatments of allergies and inflammatory and autoimmune diseases via administration of allergens, antigens using a patch to be affixed to the unbroken skin of the patient, thus avoiding the allergen being transferred into the blood; medical treatments of allergies and inflammatory and autoimmune diseases that use the epicutaneous method of desensitization via immunotherapy; epicutaneous medical treatments of allergies and inflammatory and autoimmune diseases without prior preparation of the skin other than for simple, light cleansing to keep the cellular structure of the epidermis intact; medical consultancy in the field of desensitization to allergies relating to desensitization to combat allergies	SECTION 71 - CANCELLED	—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Feb 8, 2025	DETH	DEATH OF INTERNATIONAL REGISTRATION	—
Jul 13, 2024	ADCH	CHANGE OF NAME/ADDRESS REC'D FROM IB	—
Jun 15, 2024	NREP	NEW REPRESENTATIVE AT IB RECEIVED	—
Oct 25, 2022	INNT	TOTAL INVALIDATION PROCESSED BY THE IB	—
Sep 26, 2022	INTS	TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB	—
Sep 26, 2022	INPC	INVALIDATION PROCESSED	—
Aug 24, 2022	INTR	TOTAL INVALIDATION OF REG EXT PROTECTION CREATED	—
Dec 24, 2021	C71T	CANCELLED SECTION 71	—
Nov 1, 2021	NREP	NEW REPRESENTATIVE AT IB RECEIVED	—
May 4, 2017	ADCH	CHANGE OF NAME/ADDRESS REC'D FROM IB	—
Oct 30, 2015	FINO	FINAL DECISION TRANSACTION PROCESSED BY IB	—
Sep 30, 2015	FICS	FINAL DISPOSITION NOTICE SENT TO IB	—
Sep 30, 2015	FIMP	FINAL DISPOSITION PROCESSED	—
Sep 9, 2015	FICR	FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB	—
Jun 9, 2015	R.PR	REGISTERED-PRINCIPAL REGISTER	Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 4, 2015	GPNX	NOTIFICATION PROCESSED BY IB	—
Mar 24, 2015	PUBO	PUBLISHED FOR OPPOSITION	Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 18, 2015	OPNS	NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB	—
Mar 18, 2015	OP2R	NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB	—
Mar 4, 2015	NPUB	NOTICE OF PUBLICATION	—
Feb 19, 2015	PREV	LAW OFFICE PUBLICATION REVIEW COMPLETED	—
Feb 13, 2015	ALIE	ASSIGNED TO LIE	—
Jan 27, 2015	CNSA	APPROVED FOR PUB - PRINCIPAL REGISTER	—
Jan 22, 2015	TEME	TEAS/EMAIL CORRESPONDENCE ENTERED	—
Jan 21, 2015	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Jan 21, 2015	TROA	TEAS RESPONSE TO OFFICE ACTION RECEIVED	This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 13, 2015	CNRT	NON-FINAL ACTION MAILED	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 12, 2015	CNRT	NON-FINAL ACTION WRITTEN	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 27, 2014	RFNT	REFUSAL PROCESSED BY IB	—
Dec 22, 2014	TEME	TEAS/EMAIL CORRESPONDENCE ENTERED	—
Dec 22, 2014	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Dec 22, 2014	TROA	TEAS RESPONSE TO OFFICE ACTION RECEIVED	This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 9, 2014	RFCS	NON-FINAL ACTION MAILED - REFUSAL SENT TO IB	—
Dec 9, 2014	RFRR	REFUSAL PROCESSED BY MPU	—
Dec 5, 2014	RFCR	NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW	—
Dec 5, 2014	MAFR	APPLICATION FILING RECEIPT MAILED	—
Dec 4, 2014	CNRT	NON-FINAL ACTION WRITTEN	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 1, 2014	DOCK	ASSIGNED TO EXAMINER	—
Dec 1, 2014	NWOS	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED	—
Nov 27, 2014	REPR	SN ASSIGNED FOR SECT 66A APPL FROM IB	—

DBV TECHNOLOGIES